These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33940055)

  • 1. Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking.
    Bjorness TE; Greene RW
    Pharmacol Biochem Behav; 2021 Jul; 206():173194. PubMed ID: 33940055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin/orexin deficiency decreases cocaine abuse liability.
    Steiner N; Rossetti C; Sakurai T; Yanagisawa M; de Lecea L; Magistretti PJ; Halfon O; Boutrel B
    Neuropharmacology; 2018 May; 133():395-403. PubMed ID: 29454841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operant Costs Modulate Dopamine Release to Self-Administered Cocaine.
    Oliva I; Wanat MJ
    J Neurosci; 2019 Feb; 39(7):1249-1260. PubMed ID: 30559149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine.
    Gentile TA; Simmons SJ; Barker DJ; Shaw JK; España RA; Muschamp JW
    Addict Biol; 2018 Jan; 23(1):247-255. PubMed ID: 28419646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food.
    Martin-Fardon R; Cauvi G; Kerr TM; Weiss F
    Addict Biol; 2018 Jan; 23(1):6-15. PubMed ID: 27558790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL
    Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.
    Song R; Bi GH; Zhang HY; Yang RF; Gardner EL; Li J; Xi ZX
    Neuropharmacology; 2014 Feb; 77():398-405. PubMed ID: 24176392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
    Zhou Y; Cui CL; Schlussman SD; Choi JC; Ho A; Han JS; Kreek MJ
    Neuroscience; 2008 Jun; 153(4):1225-34. PubMed ID: 18436386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
    Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists.
    Ciccocioppo R; Sanna PP; Weiss F
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1976-81. PubMed ID: 11172061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats.
    See RE; Elliott JC; Feltenstein MW
    Psychopharmacology (Berl); 2007 Oct; 194(3):321-31. PubMed ID: 17589830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
    Pei Y; Mortas P; Hoener MC; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience-dependent effects of cocaine self-administration/conditioning on prefrontal and accumbens dopamine responses.
    Ikegami A; Olsen CM; D'Souza MS; Duvauchelle CL
    Behav Neurosci; 2007 Apr; 121(2):389-400. PubMed ID: 17469929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior.
    See RE; Kruzich PJ; Grimm JW
    Psychopharmacology (Berl); 2001 Mar; 154(3):301-10. PubMed ID: 11351937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated cocaine exposure dysregulates cognitive control over cue-evoked reward-seeking behavior during Pavlovian-to-instrumental transfer.
    Marshall AT; Ostlund SB
    Learn Mem; 2018 Sep; 25(9):399-409. PubMed ID: 30115761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
    Smith RJ; See RE; Aston-Jones G
    Eur J Neurosci; 2009 Aug; 30(3):493-503. PubMed ID: 19656173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.
    Ferragud A; Velázquez-Sánchez C; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Psychopharmacology (Berl); 2009 Dec; 207(2):281-9. PubMed ID: 19756525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
    Peng XQ; Ashby CR; Spiller K; Li X; Li J; Thomasson N; Millan MJ; Mocaër E; Muńoz C; Gardner EL; Xi ZX
    Neuropharmacology; 2009 Mar; 56(4):752-60. PubMed ID: 19136017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.
    Shaw JK; Ferris MJ; Locke JL; Brodnik ZD; Jones SR; España RA
    Addict Biol; 2017 Nov; 22(6):1695-1705. PubMed ID: 27480648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.